Arterra Bioscience SpA MIL:ARBS:
9M REVENUE EUR 3.6 MILLION
Arterra Bioscience 9M Revenue EUR 3.6 Mln
Earlier from Arterra Bioscience
- ARBS: H1 2025 saw 35.5% revenue growth, 143% EBITDA increase, and robust net profit margin
- ARBS: Revenue up 12.8% year-over-year to €2.6M, led by strong cosmetic raw material sales growth
- ARBS: Q1 2025 revenue rose 21.6% year-over-year to €1.3 million, led by cosmetic raw material sales
- ARBS: Strong profit growth and R&D advances support a positive outlook and dividend proposal
- ARBS: Revenue up 28.21% to €4.2M, driven by strong cosmetic raw materials sales growth
Later from Arterra Bioscience
- Arterra Bioscience Shareholder Maria Gabriella Colucci Sells 466,500 Shares At EUR 3.20/SHR To Smart Capital
- Arterra Bioscience FY Revenue At EUR 4.6 Mln
- ARBS: Strong profit growth and innovation in cosmetic biotech drive improved margins and outlook
- Arterra Bioscience Re-Food Project Approved For Financing, Granted Non-Repayable Contribution Of Around EUR 0.5 Mln
- ARBS: Quarterly revenue up 22.21% to €1.6M, led by strong cosmetic raw material sales
Follow Arterra Bioscience into a list and get an email when it puts out news.
Follow Arterra Bioscience